Newport, Rhode Island Treatment Centers

Substance Abuse Rehabilitation Program Naval Health Clinic New England 43 Smith Road
Code 32-N
Newport, RI 02841

CODAC Behavioral Healthcare CODAC Newport 93 Thames Street
Newport, RI 02840

Newport Hospital 11 Friendship Street
Newport, RI 02840

Treatment & Detox Guide

Just How Long is Long-Term Treatment?

You’ve tried outpatient treatment, you’ve tried inpatient treatment and now you’ve been recommended for “long-term” treatment, but just how long is long-term treatment anyway and what makes it so much more effective than the programs you’ve already tried? Various recent studies have been conducted to come to the conclusion that long-term treatment is often the….

5 Reasons to Choose Long-term Drug Treatment Centers

Long-term drug treatment centers offer important advantages for patients receiving treatment for substance abuse, especially those with chronic or severe addiction. Long-term treatment differs from short-term treatment mainly in its duration, which may last from 60 days to over a year, depending on the needs of the patient. Below are five reasons to choose long-term….

Virtual world therapeautic for addicts: UH study shows

Patients in therapy to overcome addictions have a new arena to test their coping skills—the virtual world. A new study by University of Houston Associate Professor Patrick Bordnick found that a virtual reality (VR) environment can provide the climate necessary to spark an alcohol craving so that patients can practice how to say “no” in….

CENTRE OFFERS LONG-TERM ADDICTION TREATMENT FOR YOUTH

A ribbon-cutting ceremony was held today to mark a construction milestone at British Columbia’s first long-term residential treatment centre for youth challenged by addiction. The event at The Crossing at Keremeos was held to celebrate the completion of Ashnola Lodge, a residential building that will provide accommodation for 20 youth, along with space for programs…..

Cancer Immunotherapy Shows Long-Term Promise In Lung Cancer

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of….